Microbix Biosystems Inc. faces a tough day on the TSX, with shares down 3.28%.
Microbix Biosystems Inc. (MBX.TO) has seen its stock price dip by 3.28% in the latest trading session, closing at CA$0.29. This decline raises concerns among investors about the company's current financial health and market position.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$41.94M
52W high
$0.34
52W low
$0.21
1W change
+3.33%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
42.4%
Annualized
90-Day Vol
54.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.37
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.33 | C$0.28 โ C$0.38 |
| 60 trading days | C$0.35 | C$0.28 โ C$0.43 |
| 90 trading days | C$0.37 | C$0.29 โ C$0.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap of CA$40.56 million and a negative profit margin, investors should remain cautious about Microbix's financial trajectory and the potential impact on future performance.
Microbix shares fall 3.28% today
With a market cap of CA$40.56 million and a profit margin of -38.62%, Microbix's financial struggles are evident.
Bull case
Despite the challenges, thereโs a glimmer of hope for investors. Microbix reported a 13% revenue growth in their Q1 2026 report compared to the previous quarter. This suggests that the company is showing some operational resilience, which could be a positive sign moving forward.
Bear case
On the flip side, the ongoing net losses and absence of dividends highlight serious financial challenges. These factors could make potential investors think twice before getting involved with Microbix.
Market Performance Overview
In the latest trading session, Microbix Biosystems Inc. saw its stock price decrease by 3.28%, closing at CA$0.29. This decline comes amidst a broader market context where investors are increasingly cautious about companies with negative profit margins and ongoing losses.
Financial Health Concerns
With a market cap of CA$40.56 million and a troubling profit margin of -38.62%, Microbix's financial health is under scrutiny. Investors are advised to consider these metrics when evaluating the stock's potential for recovery.
Looking Ahead
As Microbix prepares to release its Q2 fiscal 2026 results, stakeholders will be keen to see if the company can turn around its financial performance and provide a more optimistic outlook for the future. For more insights, check the latest updates on Microbix Biosystems Inc..
Advertisement
